{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:26:20Z","timestamp":1780320380742,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.canrad.2023.09.004","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T12:09:38Z","timestamp":1718885378000},"page":"282-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of Graves\u2019 ophthalmopathy by radiotherapy: A literature review"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Beige","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Boustani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Truc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2023.09.004_bib0375","first-page":"477","article-title":"The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota","volume":"92","author":"Bartley","year":"1994","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.canrad.2023.09.004_bib0380","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","article-title":"Pathogenesis of Graves\u2019 ophthalmopathy","volume":"329","author":"Epstein","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.09.004_bib0385","first-page":"747","article-title":"Graves\u2019 ophthalmopathy: current concepts regarding pathogenesis and management","volume":"14","author":"Burch","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/j.canrad.2023.09.004_bib0390","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archopht.1955.00930010096010","article-title":"Visual changes in progressive exophthalmos","volume":"53","author":"Igersheimer","year":"1955","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0395","first-page":"35","article-title":"Radiation-induced alterations of the proliferation dynamics of human skin fibroblasts after repeated irradiation in the subtherapeutic dose range","volume":"171","author":"Bumann","year":"1995","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0400","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0531-5565(00)00168-6","article-title":"Spontaneous and radiation-induced differentiation of fibroblasts","volume":"35","author":"Herskind","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0405","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.1987.tb00836.x","article-title":"Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves\u2019 ophthalmopathy: a comparative study","volume":"27","author":"Marcocci","year":"1987","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0410","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF03347943","article-title":"Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves\u2019 ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study","volume":"14","author":"Marcocci","year":"1991","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.canrad.2023.09.004_bib0415","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0140-6736(93)92001-A","article-title":"Randomised double-blind trial of prednisone versus radiotherapy in Graves\u2019 ophthalmopathy","volume":"342","author":"Prummel","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2023.09.004_bib0420","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","article-title":"Radiotherapy for Graves\u2019 orbitopathy: randomised placebo-controlled study","volume":"355","author":"Mourits","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2023.09.004_bib0425","first-page":"102","article-title":"Low- versus high-dose radiotherapy for Graves\u2019 ophthalmopathy: a randomized, single blind trial","volume":"85","author":"Kahaly","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.09.004_bib0430","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0161-6420(01)00632-7","article-title":"A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves\u2019 ophthalmopathy","volume":"108","author":"Gorman","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.canrad.2023.09.004_bib0435","first-page":"3562","article-title":"Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves\u2019 ophthalmopathy: results of a prospective, single-blind, randomized study","volume":"86","author":"Marcocci","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.09.004_bib0440","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)03795-1","article-title":"Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16Gy","volume":"55","author":"Gerling","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.09.004_bib0445","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/jc.2003-030809","article-title":"A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves\u2019 ophthalmopathy","volume":"89","author":"Prummel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.09.004_bib0450","first-page":"322","article-title":"Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves\u2019 ophthalmopathy: a preliminary study","volume":"11","author":"Ng","year":"2005","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.canrad.2023.09.004_bib0455","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S2213-8587(18)30021-4","article-title":"Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2\u00d72 factorial, double-blind, randomised controlled trial","volume":"6","author":"Rajendram","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0460","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0465","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-37-2-276","article-title":"Supervoltage orbital radiotherapy for Graves\u2019 ophthalmopathy","volume":"37","author":"Donaldson","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.09.004_bib0470","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1590\/S0004-27492012000500006","article-title":"Radiation therapy for Graves\u2019 ophthalmopathy: a systematic review and meta-analysis of randomized controlled trials","volume":"75","author":"Viani","year":"2012","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0475","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2265.1980.tb03422.x","article-title":"An evaluation of supervoltage orbital irradiation for Graves\u2019 ophthalmopathy","volume":"13","author":"Teng","year":"1980","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0480","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jcem-56-6-1139","article-title":"Orbital cobalt irradiation combined with systemic corticosteroids for Graves\u2019 ophthalmopathy: comparison with systemic corticosteroids alone","volume":"56","author":"Bartalena","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.09.004_bib0485","first-page":"485","article-title":"[Radiotherapy in endocrine ophthalmopathy\u00a0\u2013\u00a0evaluation of 56 cases]","volume":"160","author":"Uhlenbrock","year":"1984","journal-title":"Strahlentherapie"},{"key":"10.1016\/j.canrad.2023.09.004_bib0490","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0002-9394(14)76027-1","article-title":"Radiation therapy for thyroid eye diseases","volume":"99","author":"Hurbli","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0495","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/0360-3016(85)90088-4","article-title":"Supervoltage radiotherapy for Graves\u2019 ophthalmopathy: CCABC technique and results","volume":"11","author":"Olivotto","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.09.004_bib0500","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF03348485","article-title":"Radiotherapy of severe ophthalmic Graves\u2019disease","volume":"8","author":"van Ouwerkerk","year":"1985","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.canrad.2023.09.004_bib0505","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/0360-3016(87)90346-4","article-title":"Radiation therapy for Graves\u2019 ophthalmopathy: a retrospective analysis","volume":"13","author":"Palmer","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.09.004_bib0510","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000309924","article-title":"Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves\u2019 ophthalmopathy","volume":"197","author":"Wiersinga","year":"1988","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.canrad.2023.09.004_bib0515","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0360-3016(89)90073-4","article-title":"Results of radiotherapy for thyroid ophthalmopathy","volume":"17","author":"Sandler","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.09.004_bib0520","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0360-3016(90)90532-O","article-title":"Prognostic factors in the radiotherapy of Graves\u2019 ophthalmopathy","volume":"19","author":"Petersen","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.09.004_bib0525","first-page":"673","article-title":"[Retrobulbar irradiation of endocrine ophthalmopathy: a comparison between 10 and 16Gy total dose]","volume":"166","author":"Pfluger","year":"1990","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0530","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(91)32114-6","article-title":"Treatment of acute Graves\u2019 orbitopathy","volume":"98","author":"Kazim","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.canrad.2023.09.004_bib0535","first-page":"13","article-title":"High-dose intravenous immunoglobulin treatment in Graves\u2019 ophthalmopathy","volume":"126","author":"Antonelli","year":"1992","journal-title":"Acta Endocrinologica"},{"key":"10.1016\/j.canrad.2023.09.004_bib0540","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/eye.1997.183","article-title":"Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease","volume":"11","author":"Claridge","year":"1997","journal-title":"Eye"},{"key":"10.1016\/j.canrad.2023.09.004_bib0545","series-title":"Radiotherapy of ocular diseases","first-page":"195","article-title":"Clinical importance of radiotherapy in the treatment of Graves\u2019 disease","author":"Friedrich","year":"1997"},{"key":"10.1016\/j.canrad.2023.09.004_bib0550","series-title":"Radiotherapy of ocular diseases","first-page":"206","article-title":"Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine orbitopathy (Graves\u2019 disease)","author":"Staar","year":"1997"},{"key":"10.1016\/j.canrad.2023.09.004_bib0555","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-129-8-199810150-00010","article-title":"Cigarette smoking and treatment outcomes in Graves\u2019 ophthalmopathy","volume":"129","author":"Bartalena","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.canrad.2023.09.004_bib0560","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF03038622","article-title":"Endokrine Orbitopathie: vergleich der Langzeitergebnisse und klassifikationen nach radiotherapie","volume":"174","author":"Seegenschmiedt","year":"1998","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0565","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/eye.2000.199","article-title":"The effect of retrobulbar irradiation on exophthalmos, ductions and soft tissue signs in Graves\u2019 ophthalmopathy: a retrospective analysis of 90 cases","volume":"14","author":"Van Ruyven","year":"2000","journal-title":"Eye"},{"key":"10.1016\/j.canrad.2023.09.004_bib0570","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0360-3016(01)01699-6","article-title":"Long-term results of irradiation for patients with progressive Graves\u2019 ophthalmopathy","volume":"51","author":"Marquez","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.09.004_bib0575","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-2002-36948","article-title":"Retrobulb\u00e4re Bestrahlung bei endokriner Orbitopathie\u00a0\u2013\u00a0Erfahrungen im Langzeitverlauf","volume":"219","author":"Pitz","year":"2002","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.canrad.2023.09.004_bib0580","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0360-3016(01)01754-0","article-title":"A long-term follow-up study after retro-orbital irradiation for Graves\u2019 ophthalmopathy","volume":"52","author":"Schaefer","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.09.004_bib0585","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1067\/mpa.2002.121170","article-title":"Radiotherapy in thyroid eye disease: the effect on the field of binocular single vision","volume":"6","author":"Ferris","year":"2002","journal-title":"J AAPOS"},{"key":"10.1016\/j.canrad.2023.09.004_bib0590","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9394(02)01970-0","article-title":"Effect of steroid pulse therapy with and without orbital radiotherapy on Graves\u2019 ophthalmopathy","volume":"135","author":"Ohtsuka","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0595","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00417-009-1214-3","article-title":"A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20Gy combined with systemic steroid treatment in patients with Graves\u2019 orbitopathy","volume":"248","author":"Johnson","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0600","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/01676830.2011.615455","article-title":"Low dose orbital radiotherapy for thyroid eye disease","volume":"30","author":"Li Yim","year":"2011","journal-title":"Orbit"},{"key":"10.1016\/j.canrad.2023.09.004_bib0605","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00417-016-3280-7","article-title":"Efficacy of combined orbital radiation and systemic steroids in the management of Graves\u2019 orbitopathy","volume":"254","author":"Kim","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0610","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13014-017-0908-7","article-title":"Clinical outcomes of Graves\u2019 ophthalmopathy treated with intensity modulated radiation therapy","volume":"12","author":"Li","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0615","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/eje.1.02230","article-title":"Clinical assessment of patients with Graves\u2019 orbitopathy: the European group on Graves\u2019 orbitopathy recommendations to generalists, specialists and clinical researchers","volume":"155","author":"Wiersinga","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0620","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2014-3014","article-title":"Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves\u2019 orbitopathy: a randomized controlled study","volume":"100","author":"Salvi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.09.004_bib0625","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/thy.2020.0269","article-title":"Efficacy profile and safety of very low-dose rituximab in patients with Graves\u2019 orbitopathy","volume":"31","author":"Vannucchi","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.canrad.2023.09.004_bib0630","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jc.2014-2572","article-title":"Randomized controlled trial of rituximab in patients with Graves\u2019 orbitopathy","volume":"100","author":"Stan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.09.004_bib0635","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.09.004_bib0640","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.09.004_bib0645","doi-asserted-by":"crossref","first-page":"e242153","DOI":"10.1136\/bcr-2021-242153","article-title":"Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease","volume":"14","author":"Hoang","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.canrad.2023.09.004_bib0650","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.3390\/jcm9092816","article-title":"Anti-IL-6 receptor tocilizumab in refractory Graves\u2019 orbitopathy: National multicenter observational study of 48 patients","volume":"9","author":"S\u00e1nchez-Bilbao","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.canrad.2023.09.004_bib0655","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ajo.2014.02.044","article-title":"Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease","volume":"157","author":"Shams","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0660","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1748-717X-7-95","article-title":"Clinical outcomes of radiotherapy as initial local therapy for Graves\u2019 ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery","volume":"7","author":"Prabhu","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0665","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/IOP.0000000000001003","article-title":"Orbital radiotherapy combined with corticosteroid treatment for thyroid eye disease-compressive optic neuropathy","volume":"34","author":"Gold","year":"2018","journal-title":"Ophthalm Plast Reconstr Surg"},{"key":"10.1016\/j.canrad.2023.09.004_bib0670","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1748-717X-7-199","article-title":"Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves\u2019 ophthalmopathy treated with retro-orbital irradiation","volume":"7","author":"Lee","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0675","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","article-title":"A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results","volume":"49","author":"Chao","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.09.004_bib0680","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11604-008-0276-1","article-title":"Intensity-modulated radiation therapy for orbital lymphoma","volume":"26","author":"Goyal","year":"2008","journal-title":"Radiat Med"},{"key":"10.1016\/j.canrad.2023.09.004_bib0685","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00066-011-2220-z","article-title":"Feasibility of tomotherapy for Graves\u2019 ophthalmopathy: dosimetry comparison with conventional radiotherapy","volume":"187","author":"Nguyen","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0690","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0028-1128141","article-title":"Effect of combined intravenous glucocorticoids and orbital radiotherapy in restoring driving competency in patients with Graves\u2019 orbitopathy","volume":"41","author":"Sterker","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.canrad.2023.09.004_bib0695","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canrad.2021.11.001","article-title":"Organs at risk radiation dose constraints","volume":"26","author":"No\u00ebl","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2023.09.004_bib0700","first-page":"e84427","article-title":"Orbital radiotherapy plus concomitant steroids in moderate-to-severe Graves\u2019 ophthalmopathy: good results after long-term follow-up","volume":"17","author":"Nicosia","year":"2019","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.09.004_bib0705","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2003-030260","article-title":"Long-term safety of orbital radiotherapy for Graves\u2019 ophthalmopathy","volume":"88","author":"Marcocci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.09.004_bib0710","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","article-title":"Orbital irradiation for Graves\u2019 ophthalmopathy","volume":"111","author":"Wakelkamp","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.canrad.2023.09.004_bib0715","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/s41598-019-38640-5","article-title":"Predictive factors of prognosis after radiation and steroid pulse therapy in thyroid eye disease","volume":"9","author":"Ito","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.canrad.2023.09.004_bib0720","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijrobp.2010.08.053","article-title":"The efficacy of radiation therapy in the treatment of Graves\u2019 orbitopathy","volume":"82","author":"Matthiesen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.09.004_bib0725","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0167-8140(99)00118-8","article-title":"Assessment of a carcinogenic risk for treatment of Graves\u2019 ophthalmopathy in dependence on age and irradiation geometry","volume":"53","author":"Broerse","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0730","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0167-8140(95)01670-8","article-title":"Probable risk of tumour induction after retro-orbital irradiation for Graves\u2019 ophthalmopathy","volume":"38","author":"Snijders-Keilholz","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.09.004_bib0735","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000070050","article-title":"The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves\u2019 orbitopathy","volume":"35","author":"Akmansu","year":"2003","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.canrad.2023.09.004_bib0740","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1002\/mp.13130","article-title":"Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves\u2019 orbitopathy","volume":"45","author":"Mazonakis","year":"2018","journal-title":"Med Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T02:45:02Z","timestamp":1719715502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321824000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1278321824000660"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2023.09.004","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Graves\u2019 ophthalmopathy by radiotherapy: A literature review","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2023.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}